RECURRENT BREAST CARCINOMA
Clinical trials for RECURRENT BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy may keep breast cancer from coming back
Disease control CompletedThis study tested whether adding ovarian suppression (stopping the ovaries from making estrogen) and switching to a different hormone drug (exemestane) could better prevent breast cancer from returning in premenopausal women with hormone-sensitive breast cancer. Over 3,000 women …
Matched conditions: RECURRENT BREAST CARCINOMA
Phase: PHASE3 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New combo therapy targets tough cancers in early trial
Disease control CompletedThis early-phase study tested a new drug (ALRN-6924) combined with standard chemotherapy (paclitaxel) in 28 adults with advanced solid tumors that had spread or couldn't be removed surgically, including a type of breast cancer. The main goal was to find the safest dose and check …
Matched conditions: RECURRENT BREAST CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New hope for Hard-to-Treat breast cancer? trial tests drug combo
Disease control CompletedThis study tested whether adding the drug veliparib to standard chemotherapy (cisplatin) helps people with advanced triple-negative or BRCA-related breast cancer, including those with brain tumors. About 344 participants were enrolled. The goal was to see if the combination could…
Matched conditions: RECURRENT BREAST CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
Focused radiation beams take aim at multiple tumors in early trial
Symptom relief CompletedThis early-stage study tested a precise, high-dose radiation technique called stereotactic body radiotherapy (SBRT) in 42 people with breast, lung, or prostate cancer that had spread to several places in the body. The main goal was to find the safest dose and check for side effec…
Matched conditions: RECURRENT BREAST CARCINOMA
Phase: PHASE1 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 26, 2026 08:33 UTC